Psoriasis is known to be associated with increased risk of cardiovascular diseases. High‐
sensitivity C‐reactive protein (hs‐CRP) is a marker of inflammation and an independent risk …

Background: There is a paucity of studies addressing the elevation of C-reactive protein
(CRP) among psoriatic patients and the role of this marker in assessment of disease severity …

Psoriasis is a chronic inflammatory skin disease, which may be associated with metabolic
syndrome accompanied by cardio‐and cerebrovascular diseases. We investigated the …

Psoriasis vulgaris is associated with an increased risk of atherosclerosis. The C-Reactive
Protein-to-Albumin Ratio (CAR) has received increasing attention as an independent …

Background C‐reactive protein (CRP), an inflammation biomarker, indicates cardiovascular
risk and is elevated in psoriasis. The effect of etanercept on CRP in psoriasis has not been …

Background Psoriasis is a chronic inflammatory disease of the skin and joints that may also
have systemic inflammatory effects, including the development of cardiovascular disease …

Objective Patients with psoriasis are prone to premature atherosclerosis and increased risk
of cardiovascular disease events. However, the prevalence and extent of atherosclerosis in …

Objectives: Systemic inflammation plays an important role in the pathogenesis of
atherosclerosis in psoriasis patients. Therefore, persistent skin inflammation in psoriasis …

Psoriasis is linked with increased risk of cardiovascular disease (CVD) that is
underestimated by traditional risk stratification. We conducted a large-scale plasma …

Psoriasis is a systemic inflammatory disease of the skin with associated comorbidity. Severe
forms of psoriasis are associated with increased mortality, which might be due to …